Navigation Links
Major Adult Vaccine Clinical Trial for Pneumonia Prevention Begins
Date:9/23/2008

- 85,000 Expected to Enroll in Phase 4 Study Initiated Pre-Registration -

COLLEGEVILLE, Pa., Sept. 23 /PRNewswire/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced the initiation of the Community Acquired Pneumonia Immunization Trial in Adults a major study in adults of an investigational 13-valent conjugate vaccine designed to help prevent pneumococcal pneumonia -- the leading cause of bacterial pneumonia in adults.

In Europe and the United States, pneumococcal pneumonia is the most common community-acquired bacterial pneumonia, for which the adult mortality rate averages between 10 to 20 percent. That rate may exceed 50 percent in high-risk groups worldwide.

The results from this trial are not intended or required for inclusion in Wyeth's currently planned regulatory filings for the use of the 13-valent pneumococcal conjugate candidate vaccine in adults. Rather, this study is being initiated proactively as part of a Phase 4 commitment, and in agreement with the U.S. Food and Drug Administration (FDA).

The Community Acquired Pneumonia Immunization Trial in Adults is a double-blind, placebo-controlled study expected to enroll approximately 85,000 participants 65 years of age and older. The study is being conducted by the Julius Center for Health Sciences and Primary Care at the University Medical Center Utrecht in the Netherlands. Participants in the trial will receive either Wyeth's investigational 13-valent pneumococcal conjugate vaccine or placebo.

"We are very excited to conduct this major trial addressing the important disease of adult pneumonia," says Marc Bonten, M.D., principal investigator of the trial and Professor of Molecular Epidemiology of Infectious Diseases, D
'/>"/>

SOURCE Wyeth Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
2. Weil Gotshal Wins Major Victory for Applera; Secures Summary Judgment Invalidating Three Patents
3. Radius Grants Major Pharmaceutical Company Exclusive Option to License BA058 for Osteoporosis
4. Genzyme Begins Major Expansion of Boston Manufacturing Facility
5. International Atomic Energy Agency and National Foundation for Cancer Research Launch Major Initiative to Improve Cancer Prevention and Treatments in Developing Countries
6. Forest Laboratories Lexapro and Generics-Dominated Fluoxetine Lead First-Line Therapy in the Treatment for Major Depression
7. Updated Drug Development Scrip Report Responds to the Pharma Industrys Major Changes
8. National Surgical Hospitals Acquires Majority Share of Houston-Area Surgery Center
9. Agendia Acquires Rights to the Discovery of a Major Drug Resistance Mechanism in Breast Cancer Potentially Leading to a Herceptin(R) Sensitivity Test
10. Bioponic Phytoceuticals to Roll Out Multiple Products to 1,000 Major Health Food Stores in the Western United States
11. SPO Medical Announces Major Sales Milestone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... Norris, TN (PRWEB) September 16, 2014 ... several new initiatives to position themselves for ... capabilities for labeling and encoding, Pharma Packaging ... adding new hardware and software and new ... on current Good Manufacturing Practices (cGMP), Pharma ...
(Date:9/16/2014)... Oro Valley, Arizona (PRWEB) September 16, 2014 ... company that develops safe and effective products to ... through the use of a proprietary SPACEā„¢ Technology ... Executive Officer and President will present at the ... 18, 2014 at the Hyatt Regency Phoenix. ...
(Date:9/16/2014)... , Sept. 16, 2014  LABSCO, the ... and products to hospitals, physician office laboratories and ... effective October 1, 2014, it will serve as ... hospital market segments and as a semi-exclusive sales ... 48 contiguous United States . ...
(Date:9/16/2014)... 16, 2014 /PRNewswire-iReach/ -- Researchers found that ActiveLife ... patients with bone fragility fracture when today,s standard ... worldwide are at risk of fracture for reasons ... strength test, the DEXA bone density scan.  Study ... Bone and Mineral Research Annual Conference (ASBMR) in ...
Breaking Biology Technology:Adding Serialization Capabilities and Expanded Capacity, Pharma Packaging Solutions Is Preparing for 89th Year of Business 2Convoy Therapeutics to Present at WhiteHat Investor Conference September 18, 2014 2Convoy Therapeutics to Present at WhiteHat Investor Conference September 18, 2014 3LABSCO Secures Alliance With Siemens Healthcare Diagnostics 2LABSCO Secures Alliance With Siemens Healthcare Diagnostics 3ActiveLife's BMSi Test Provides Hope for 160 Million with Undetectable Risk of Bone Fracture 2ActiveLife's BMSi Test Provides Hope for 160 Million with Undetectable Risk of Bone Fracture 3
... Barr,Pharmaceuticals, Inc. (NYSE: BRL ) today ... approval from the U.S. Food & Drug,Administration (FDA) ... version of Forest Pharmaceuticals, Inc.,s Combunox(R) (oxycodone,HCl and ... of the New Combination exclusivity period for Combunox. ...
... N.C., Nov. 29 Kent Riddle, Director,Product Development, for ... to head development initiatives within the Medical,Biodevice Sector. The ... the growth of bioscience in North Carolina., "I ... part of this important,group," says Riddle. "DPI is at ...
... The Center for Molecular,Medicine (CMM) today announced ... Xceed,Molecular (http://www.xceedmolecular.com ; Wellesley, MA) collaborator program., ... US site to offer Xceed Molecular,s new,Ziplex(R) system ... tool in disease investigation and drug discovery. Analysis ...
Cached Biology Technology:Barr Receives Approval for Generic Combunox(R) Tablets, 5mg/400mg 2Barr Receives Approval for Generic Combunox(R) Tablets, 5mg/400mg 3Center for Molecular Medicine Offers Xceed Ziplex(TM) Services to Research Community 2
(Date:9/15/2014)... generally considered to be a disorder of brain development ... environmental, with other neurodevelopmental disorders such as autism and ... is determined by the combined effects of a complex ... factors. , However, longitudinal brain imaging studies in both ... map the disturbances in brain structures as they emerge, ...
(Date:9/15/2014)... the balance between ridding the body of a dangerous ... report appearing in The Journal of Experimental ... cause chronic infections in roughly three-quarters of infected people, ... including cirrhosis and cancer. A few patients successfully eliminate ... + T cells. The protective effects of CD8 ...
(Date:9/15/2014)... German . ... energy carrier natural gas offers a variety of options ... consequent market penetration is still pending because of a ... the Helmholtz Centre for Environ-mental Research (UFZ) and the ... the IEA Task 37 (Energy from Biogas) and the ...
Breaking Biology News(10 mins):Brain Development in Schizophrenia Strays from the Normal Path 2The biomethane market needs clear frame conditions for further growth 2The biomethane market needs clear frame conditions for further growth 3
... The Pollution Prevention Institute at Kansas State University is ... National Pollution Prevention Roundtable. The K-State institute,s intern ... Prevention Program award, also called the MVP2 award, as ... presented Tuesday, Sept. 22, in Washington, D.C. The ...
... - NiKem Research is pleased to announce that ... certification of its bioanalysis facilities to further extend its drug ... years high quality cost-effective bioanalytical support both for its ... PK services associated to various drug discovery programs and as ...
... new study shows that parents are more likely to understand ... a traffic light, than the standard charts currently in use. ... to parent could lead to parents earlier awareness of their ... lifestyle changes," says Eliana Perrin, M.D., M.P.H., senior and corresponding ...
Cached Biology News:K-State Pollution Prevention Institute's intern program named best 2NiKem Research receives certification for GLP Bioanalysis 2UNC study: Color-coded chart improves parents' understanding of body mass index 2
... power of your ValveBank system! Program ... a Macintosh computer using graphic 'click-and-drag' timebars. ... print out program listings, then download your ... simple step., EasyCode is used for programming ...
...
... The Jouan MSC series of ... comfortable working conditions and certification to ... automatic regulation ensures that the cabinets ... working conditions. Natural lighting, low noise ...
... HB-1000 Hybridizer hybridization ovens are designed to create ... Temperature control (ambient to 99.9C) , ... consistent saturation of samples, whether it be for ... which displays the current temperature inside the chamber, ...
Biology Products: